Skip to main content
Equibles

ExodusPoint Capital Management, LP

Position in MLTX — MoonLake Immunotherapeutics

CIK 1736225 NEW YORK, NY
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$908,197
-$1,334,381 QoQ
Shares Held
46,646
-61.2% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#84
of 172 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Derivatives in MLTX

reported options exposure · as of Sep 30, 2025
CallValue
$215,100
CallShares
30,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names. MLTX ranks #60 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CYTK
Cytokinetics Inc
 249,259 $21,234,374
2 BBIO
BridgeBio Pharma, Inc.
 224,927 $16,752,562
3 ORKA
Oruka Therapeutics, Inc.
 148,212 $14,105,336
4 VKTX
Viking Therapeutics, Inc.
 361,126 $14,087,525
5 JAZZ
Jazz Pharmaceuticals plc
 53,201 $12,819,844
6 NAMS
NewAmsterdam Pharma Co N.V.
 304,334 $10,313,879
7 TGTX
Tg Therapeutics, Inc.
 164,513 $9,038,344
8 DNLI
Denali Therapeutics Inc.
 336,567 $8,656,503

All Filings in MLTX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $908,197 46,646
2026-03-31 $2,242,578 120,310
2025-12-31 $2,807,287 212,996
2025-09-30 $215,100 30,000
2025-06-30 $1,194,773 25,313
2024-09-30 $849,829 16,855
2023-12-31 $1,716,102 28,417
2023-09-30 $2,575,317 45,181